Allergies Clinical Trial
Official title:
Omega-3 Fatty Acid Supplementation in Pregnancy and During Lactation: a Randomized, Double-Blind, Placebo Controlled Trial.
The incidence of allergic diseases has increased and a relation between allergy and dietary fatty acids has been proposed. Modulation of the maternal immune function during pregnancy may have an impact on future clinical outcomes in the child. The aim of this study was to determine the effects of omega (ω) - 3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation during pregnancy and lactation on the development of allergic disease (i.e., allergic eczema) in the child at 2 years of age. Pregnant women with allergic disease in their immediate family were supplemented daily with 2.7 g ω-3 LCPUFA (n=70) or 2.8 g soybean-oil as placebo (n=75) from gestational week (gw) 25 until the third month of breastfeeding. Skin prick tests, detection of circulating specific IgE antibodies and clinical examinations of the infants were performed at 3, 6, 12 and 24 months of age. The mothers and children were monitored regarding immune modulatory effects during the entire study period.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01612936 -
T Cell Effector and Regulatory Mechanisms in Asthma
|
Phase 1 | |
| Completed |
NCT00779116 -
Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)
|
Phase 4 | |
| Recruiting |
NCT06002685 -
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
|
N/A | |
| Completed |
NCT04644783 -
Novel Blood Test to Predict Safe Foods for Infants and Toddlers With Food Protein-induced Enterocolitis Syndrome (FPIES)
|
N/A | |
| Recruiting |
NCT05635266 -
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
|
||
| Completed |
NCT01792232 -
Effects of Co-Exposure to Air Pollution and Allergen
|
N/A | |
| Completed |
NCT01454505 -
Safety and Efficacy of AL-53817 Nasal Spray Solution
|
Phase 1 | |
| Completed |
NCT00800332 -
Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy
|
Phase 2 | |
| Terminated |
NCT04641000 -
The Alberta BLOOM Long Term Follow Up Study
|
||
| Recruiting |
NCT05119868 -
Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring
|
N/A | |
| Completed |
NCT00801502 -
Salmon in Pregnancy Study
|
N/A | |
| Completed |
NCT00453583 -
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
|
N/A | |
| Completed |
NCT00700726 -
Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma
|
N/A | |
| Recruiting |
NCT00350376 -
Impact of Asthma Treatments on Daily Activities
|
N/A | |
| Completed |
NCT00881634 -
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions
|
Phase 1 | |
| Completed |
NCT00881127 -
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions
|
Phase 1 | |
| Completed |
NCT03106493 -
Upstate New York Infant Development Screening Program
|
||
| Completed |
NCT02017431 -
Air Pollution and Allergens - Attenuation of Health Effects Particle Reduction
|
N/A | |
| Completed |
NCT01711593 -
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
|
Phase 1 | |
| Completed |
NCT01529437 -
Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
|
Phase 1 |